newsfilter
← Latest News
Business Wire·

Exicure, Inc. Reports Third Quarter 2023 Financial Results

Exicure, Inc. (NASDAQ:XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company